Royce & Associates LP Medpace Holdings, Inc. Transaction History

Royce & Associates LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$284.87 - $413.31 $224,192 - $325,274	-787 Reduced 7.5%	9,713 $3.93 Million
Q4 2023 Feb 12, 2024	BUY	$227.52 - $312.68 $2.39 Million - $3.28 Million	10,500 New	10,500 $3.22 Million
Q1 2022 May 05, 2022	SELL	$138.87 - $214.31 $2.08 Million - $3.21 Million	-15,000 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$170.18 - $198.21 $96,662 - $112,583	-568 Reduced 3.65%	15,000 $2.84 Million
Q1 2021 May 10, 2021	SELL	$132.02 - $168.26 $475,139 - $605,567	-3,599 Reduced 18.78%	15,568 $2.55 Million
Q4 2019 Feb 06, 2020	BUY	$70.08 - $84.64 $38,964 - $47,059	556 Added 2.99%	19,167 $1.61 Million
Q3 2019 Nov 13, 2019	BUY	$62.38 - $85.89 $911,434 - $1.25 Million	14,611 Added 365.28%	18,611 $1.56 Million
Q1 2019 May 09, 2019	BUY	$49.38 - $70.58 $197,520 - $282,320	4,000 New	4,000 $236,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.3B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.